YOU MATTER.
Upcoming Events
Charlotte Kidney Cancer Support Group – Holiday Luncheon
November 26 @ 1:00 pm - 3:30 pm
Publications
0
%
5-Year Survival Rate Percentage increase from 2007 through 2013
0
Estimated new cases in the US, this year
0
Estimated Deaths in the US, this year
0
People are living with kidney and renal pelvis cancer, according to NCI SEER data from 2014
Evaluate your treatment options and make decisions
From the Pressroom
News from Kidney Cancer Association This feed has been created by Kidney Cancer Association
-
Trials Presented at ESMO 2018
on November 14, 2018 at 4:31 pm
In patients with previously untreated advanced renal cell carcinoma (RCC) whose tumors were positive for the PD-L1 checkpoint, a combination of the checkpoint inhibitor avelumab and the tyrosine kinase inhibitor (TKI) axitinib increased the median PFS from 8.4 months to 13.8 months when compared […]
-
Phase 1 study of everolimus and low-dose oral...
on November 14, 2018 at 4:24 pm
mTOR inhibitors are frequently used in the treatment of metastatic renal cell cancer (mRCC). mTOR regulates cell growth, proliferation, angiogenesis, and survival, and additionally plays an important role in immune regulation. Since mTOR inhibitors were shown to benefit immunosuppressive regulatory […]
-
CIP2A Promotes Proliferation, Invasion and...
on November 14, 2018 at 4:21 pm
CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal cell carcinoma (RCC) development is poorly understood.11/14/2018 […]
YOU MATTER.
WE CARE.
YOU ARE NOT ALONE.
Kidney Cancer Association
The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers.
MDACC 2018: Systemic Therapy for Metastatic Non-Clear Cell Histology Patients: What Works and What Doesn’t?
MDACC 2018 when to choose chemotherapy versus targeted therapy in non-clear cell histology, Anti-VEGF TKIs, Sunitinib, Pazopanib, Axitinib, Cabozanitinib, first line or salvage options in non-clear cell RCCs with Sunitinib being the preferred option based on the ASPEN, ESPN, and RECORD-3 trial.
urotoday.com
Immunotherapy/TKI Combinations in Advanced RCC
Robert A. Figlin, MD, director, Division of Hematology/Oncology, professor of biomedical sciences and medicine, Cedars-Sinai Medical Center, discusses the potential for immunotherapy/TKI combinations in the treatment of advanced renal cell carcinoma.
targetedonc.com
Front-Line Combo Found Superior for Advanced RCC
Avelumab plus axitinib combo prolongs progression-free survival compared with sunitinib as first-line therapy in patients with advanced RCC
renalandurologynews.com
1 day ago
The latest Cancer News Daily! https://t.co/05hNMEec8O Thanks to @GraceDiam @realchuckbearry @AJRAllModCons #cancer #breastcancer
The latest Cancer News Daily! https://t.co/05hNMEec8O Thanks to @GraceDiam @realchuckbearry @AJRAllModCons #cancer #breastcancer
The latest Cancer News Daily! https://t.co/05hNMEec8O Thanks to @GraceDiam @realchuckbearry @AJRAllModCons #cancer #breastcancer
— Kidney Cancer (@KidneyCancer) November 14, 2018
2 days ago
The latest Cancer News Daily! https://t.co/nCvvl97g2g Thanks to @Hall4Loren @60F2013P @ski4cancer #cancer #charity
The latest Cancer News Daily! https://t.co/nCvvl97g2g Thanks to @Hall4Loren @60F2013P @ski4cancer #cancer #charity
The latest Cancer News Daily! https://t.co/nCvvl97g2g Thanks to @Hall4Loren @60F2013P @ski4cancer #cancer #charity
— Kidney Cancer (@KidneyCancer) November 13, 2018
2 days ago
The latest Cancer News Daily! https://t.co/leRUdnlPnX Thanks to @cleaneatscarrie @SSSandied53 @DHUNTtweets #cancer #breastcancer
The latest Cancer News Daily! https://t.co/leRUdnlPnX Thanks to @cleaneatscarrie @SSSandied53 @DHUNTtweets #cancer #breastcancer
The latest Cancer News Daily! https://t.co/leRUdnlPnX Thanks to @cleaneatscarrie @SSSandied53 @DHUNTtweets #cancer #breastcancer
— Kidney Cancer (@KidneyCancer) November 13, 2018